Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation
- PMID: 33314312
- PMCID: PMC8285924
- DOI: 10.1002/mds.28411
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation
Abstract
Idiopathic Parkinson's disease (iPD) is a movement disorder characterized by the degeneration of dopaminergic neurons and aggregation of the protein α-synuclein. Patients with iPD vary in age of symptom onset, rate of progression, severity of motor and non-motor symptoms, and extent of central and peripheral inflammation. Genetic and environmental factors are believed to act synergistically in iPD pathogenesis. We propose that environmental factors (pesticides and infections) increase the risk for iPD via the immune system and that the role of PD risk genes in immune cells is worthy of investigation. This review highlights the major PD-relevant genes expressed in immune cells and key environmental factors that activate immune cells and, alone or in combination with other factors, may contribute to iPD pathogenesis. By reviewing these interactions, we seek to enable the future development of immunomodulatory approaches to prevent or delay onset of iPD. © 2020 International Parkinson and Movement Disorder Society.
Keywords: immune; LRRK2; gene by environment; MHCII; inflammation.
© 2020 International Parkinson and Movement Disorder Society.
Conflict of interest statement
Conflicts of Interests
MGT is a current member of advisory boards for the W. Garfield Weston Foundation advisory board, the World Parkinson Coalition, the Quebec Parkinson’s Network, the Michael J. Fox Foundation for Parkinson’s Research, the Alzheimer’s Association Medical and Scientific Advisory Board, and has active collaborations/consults with/for INmune Bio, Denali, Merck, Biogen/Ionis, Lundbeck, Longevity Bio, Cerebral Therapeutics, and Prevail Therapeutics. ABW is a current member of the Michael J. Fox Foundation for Parkinson’s Research Executive Scientific Advisory Board and consults for EscapeBio Inc. and Neuro23 Inc. CK is a medical advisor to Centogene for genetic testing reports in the fields of movement disorders and dementia, excluding Parkinson’s disease.
Figures
References
-
- Domingo A and Klein C, Genetics of Parkinson disease. Handb Clin Neurol, 2018. 147: p. 211–227. - PubMed
-
- Jimenez-Ferrer I and Swanberg M, Immunogenetics of Parkinson's Disease, in Parkinson's Disease: Pathogenesis and Clinical Aspects, Stoker TB and Greenland JC, Editors. 2018: Brisbane (AU).
-
- Hirsch EC and Standaert DG, Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease. Mov Disord, 2020. - PubMed
-
- Braak H, et al., Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 2003. 24(2): p. 197–211. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
